NVCR – novocure limited - ordinary shares (US:NASDAQ)
Stock Stats
News
1/3
07:00 am
nvcr
Low
Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference
12/13
08:31 am
nvcr
High
NovoCure Limited (NASDAQ: NVCR) had its price target raised by analysts at Piper Sandler from $28.00 to $42.00. They now have an "overweight" rating on the stock.
12/2
06:11 pm
nvcr
Low
NovoCure Limited (NASDAQ: NVCR) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $29.00 price target on the stock, up previously from $24.00.
12/2
12:19 pm
nvcr
Medium
NovoCure Limited (NASDAQ: NVCR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock, up previously from $30.00.
12/2
07:08 am
nvcr
High
NovoCure Limited (NASDAQ: NVCR) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $30.00 price target on the stock, up previously from $18.00.
10/30/2024
07:00 am
nvcr
-2.8%
BEAT
7/25/2024
07:00 am
nvcr
-0.8%
BEAT
5/2/2024
07:00 am
nvcr
9.2%
BEAT
2/22/2024
07:00 am
nvcr
-3.2%
BEAT
12/2
06:11 pm
Reiterates
Neutral
Wedbush
Low
1.9%
12/2
06:11 pm
Reiterates
Neutral
Wedbush
Low
1.9%
12/2
12:19 pm
Reiterates
Buy
Buy
HC Wainwright
Medium
3.3%
12/2
07:08 am
Upgrades
In-Line
Outperform
Evercore ISI
High
35.4%
12/2
07:08 am
Upgrades
In-Line
Outperform
Evercore ISI
High
35.4%
1/3
04:04 pm
nvcr
Low
Form 4 NovoCure Ltd For: Jan 01 Filed by: Danziger Asaf
1/3
04:04 pm
nvcr
Low
Form 4 NovoCure Ltd For: Dec 31 Filed by: Ben Arye Barak
1/3
04:04 pm
nvcr
Low
Form 4 NovoCure Ltd For: Dec 31 Filed by: Cordova Ashley
1/2
04:26 pm
nvcr
Low
Form 144 NovoCure Ltd Filed by: GROENHUYSEN WILHELMUS CM
12/17
06:03 am
nvcr
Low
Form 8-K/A NovoCure Ltd For: Aug 30
Show more
Top News Gainers
1/16 Novocure Ltd (NASDAQ: NVCR) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 11.0%
7/25 Q2/2019 6/30/2019 EPS -0.010 ZacksConsensus -0.070 ActVsEst 0.060 - Beat 8.6%
3/19 Novocure Announces Optune Lua™ as the Brand Name for the NovoTTF-100L™ System 8.2%
3/4 Novocure Ltd (NASDAQ: NVCR) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 7.8%
4/7 Novocure Ltd (NASDAQ: NVCR) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a price target on the stock. 7.7%
5/23 FDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma 7.3%
6/27 Novocure Ltd (NASDAQ: NVCR) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. 7.1%
8/14 Form 4 NovoCure Ltd For: Aug 12 Filed by: LEUNG GABRIEL 5.2%
10/31 NovoCure Limited (NVCR) CEO Asaf Danziger on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 5.2%
1/7 Novocure Ltd (NASDAQ: NVCR) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $91.00 price target on the stock. 5.2%
Top News Decliners
4/30 Q1/2020 3/31/2020 EPS 0.040 ZacksConsensus 0.050 ActVsEst (0.010) - Miss -12.1%
3/20 German Federal Joint Committee Updates Medical Care Directive to include Tumor Treating Fields, establishing National Reimbursement for Optune in Germany -10.5%
4/7 Novocure Ltd (NASDAQ: NVCR) had its price target lowered by analysts at Wells Fargo & Co from $90.00 to $82.00. They now have an "overweight" rating on the stock. -9.6%
5/1 Novocure Ltd (NASDAQ: NVCR) had its "hold" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $78.00 price target on the stock. -8.4%
9/9 Novocure Announces 27 Presentations at the American Society for Radiation Oncology 2019 Annual Meeting -8.3%
3/10 Form 4 NovoCure Ltd For: Mar 06 Filed by: GROENHUYSEN WILHELMUS CM -8.1%
1/2 Novocure Ltd (NASDAQ: NVCR) was downgraded by analysts at Evercore ISI to an "outperform" rating. -7.9%
3/2 Form 4 NovoCure Ltd For: Feb 27 Filed by: Shah Pritesh -7.4%
10/25 Novocure Ltd (NASDAQ: NVCR) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $79.00 price target on the stock. -6.6%
1/13 Form 8-K NovoCure Ltd For: Jan 10 -5.6%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3